Literature DB >> 22808308

Presentation of reticulate acropigmentation of kitamura and dowling-degos disease overlap.

Jennifer C Tang, Julia Escandon, Michael Shiman, Brian Berman.   

Abstract

The authors report a case of overlapping reticulate acropigmentation of Kitamura and Dowling-Degos disease seen in a 57-year-old woman. This is a unique presentation of two rare entities that some believe to be the same disease with variable phenotypic expression. This is an interesting case of reticulated pigmentation that unfortunately has limited treatment options.

Entities:  

Year:  2012        PMID： 22808308      PMCID： PMC3366449     

Source DB:  PubMed          Journal:  J Clin Aesthet Dermatol        ISSN： 1941-2789


  8 in total

1.  Galli-Galli disease: an unrecognized entity or an acantholytic variant of Dowling-Degos disease?

Authors:  M Braun-Falco; W Volgger; S Borelli; J Ring; R Disch
Journal:  J Am Acad Dermatol       Date:  2001-11       Impact factor: 11.527

2.  Effectiveness of topical adapalene in Dowling-Degos disease.

Authors:  G Altomare; G L Capella; C Fracchiolla; E Frigerio
Journal:  Dermatology       Date:  1999       Impact factor: 5.366

3.  Successful treatment of Dowling-Degos disease with Er:YAG laser.

Authors:  Joerg Wenzel; Katja Tappe; Rainer Gerdsen; Manfred Uerlich; Wolfgang Philipp-Dormston; Thomas Bieber; Welisar Petrow
Journal:  Dermatol Surg       Date:  2002-08       Impact factor: 3.398

4.  [Reticulated pigmentary dermatosis of the folds: relation to acanthosis nigricans].

Authors:  R DEGOS; B OSSIPOWSKI
Journal:  Ann Dermatol Syphiligr (Paris)       Date:  1954 Mar-Apr

5.  The spectrum of Dowling-Degos disease.

Authors:  A Rebora; F Crovato
Journal:  Br J Dermatol       Date:  1984-05       Impact factor: 9.302

6.  Treatment of reticulate acropigmentation of Kitamura with azelaic acid. An immunohistochemical and electron microscopic study.

Authors:  K Kameyama; M Morita; K Sugaya; S Nishiyama; V J Hearing
Journal:  J Am Acad Dermatol       Date:  1992-05       Impact factor: 11.527

7.  Changing a concept--controversy on the confusing spectrum of the reticulate pigmented disorders of the skin.

Authors:  Cornelia S L Müller; Claudia Pföhler; Wolfgang Tilgen
Journal:  J Cutan Pathol       Date:  2008-06-17       Impact factor: 1.587

8.  [Dowling-Degos disease: unsuccessful therapeutic trial with retinoids].

Authors:  G Oppolzer; T Schwarz; P Duschet; W Brenner; F Gschnait
Journal:  Hautarzt       Date:  1987-10       Impact factor: 0.751
  8 in total
  5 in total

1.  Pathogenicity of POFUT1 in Dowling-Degos disease: additional mutations and clinical overlap with reticulate acropigmentation of kitamura.

Authors:  F Buket Basmanav; Günter Fritz; Gilles G Lestringant; Divya Pachat; Sabine Hoffjan; Johannes Fischer; Maria Wehner; Sabrina Wolf; Holger Thiele; Janine Altmüller; Susanne A Pulimood; Arno Rütten; Roland Kruse; Sandra Hanneken; Jorge Frank; Sumita Danda; Anette Bygum; Regina C Betz
Journal:  J Invest Dermatol       Date:  2014-09-17       Impact factor: 8.551

2.  Acral freckling with palmar pits.

Authors:  Keshavmurthy A Adya; Arun C Inamadar; Aparna Palit
Journal:  Indian Dermatol Online J       Date:  2015 May-Jun

3.  Association of Dowling-Degos disease and multiple seborrheic keratosis in a "Christmas tree pattern".

Authors:  Vitorino Modesto Dos Santos; Nayanne Lays Dos Santos Pereira; Renata Faria Silva; Fabio Henrique de Oliveira Silva; Cacilda Joyce Ferreira da Silva Garcia; Maria Aparecida Alves de Figueiredo Sousa
Journal:  Med J Islam Repub Iran       Date:  2014-07-15

Review 4.  Clinical and Genetic Review of Hereditary Acral Reticulate Pigmentary Disorders.

Authors:  H Alshaikh; F Alsaif; S Aldukhi
Journal:  Dermatol Res Pract       Date:  2017-10-23

5.  The First Report of KRT5 Mutation Underlying Acantholytic Dowling-Degos Disease with Mottled Hypopigmentation in an Indian Family.

Authors:  Shyam Verma; Sandra M Pasternack; Arno Rütten; Thomas Ruzicka; Regina C Betz; Sandra Hanneken
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.